ROCKVILLE CENTRE DRUG AND ALCOHOL ABUSE - CONFIDE INC
AI Summary
ROCKVILLE CENTRE DRUG AND ALCOHOL ABUSE - CONFIDE INC is dedicated to providing essential drug and alcohol treatment services, focusing on substance abuse treatment. With an operating budget of $782.2K and total revenue of $774.1K for the 2024 filing year, the organization plays a vital role in addressing addiction issues in its community. For more information, visit www.confidervc.us.
Mission Statement
TO PROVIDE DRUG AND ALCOHOL TREATMENT SERVICES.
Cause Areas
1
Substance abuse treatment
Explore this org's ecosystem
See similar nonprofits by cause and location, their funders, and their grants.
Explore this org's ecosystem
See similar nonprofits by cause and location, their funders, and their grants.
Charity Verification Snapshot
IRS EO Business Master File Status
Listed as tax-exempt
IRS Pub 78 Status
Eligible for tax-deductible gifts
IRS Revocation Status
Not in Automatic Revocation of Exemption List
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Frequently Asked Questions
What is ROCKVILLE CENTRE DRUG AND ALCOHOL ABUSE - CONFIDE INC’s budget?
In 2024, ROCKVILLE CENTRE DRUG AND ALCOHOL ABUSE - CONFIDE INC reported an annual operating budget of around $782 thousand. More detailed financial information is available to registered users.
What causes does ROCKVILLE CENTRE DRUG AND ALCOHOL ABUSE - CONFIDE INC support?
ROCKVILLE CENTRE DRUG AND ALCOHOL ABUSE - CONFIDE INC supports work in Substance abuse treatment.
Where does ROCKVILLE CENTRE DRUG AND ALCOHOL ABUSE - CONFIDE INC operate?
ROCKVILLE CENTRE DRUG AND ALCOHOL ABUSE - CONFIDE INC is headquartered in Rockville Centre, NY.
What is ROCKVILLE CENTRE DRUG AND ALCOHOL ABUSE - CONFIDE INC’s reliance on government grants?
ROCKVILLE CENTRE DRUG AND ALCOHOL ABUSE - CONFIDE INC relied on government grants for more than 65% of their total revenue in 2024.